Address long term follow up: One year safety and efficacy evaluation

被引：0
|
作者：
Abraham, E
Laterre, PF
Janes, J
Correll, N
Trzaskoma, B
Booth, FV
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[2] St Luc Univ Hosp, Intens Care Unit, Brussels, Belgium
[3] Eli Lilly & Co, Lilly Res Labs, Erl Wood, England
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A150 / A150
页数：1
相关论文
共 50 条
  • [31] Opicapone long-term efficacy and safety in Parkinson's disease BIPARK-II study: a one-year open-label follow-up
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 171 - 171
  • [32] Opicapone long-term efficacy and safety in Parkinson's disease BIPARK-II study: a one-year open-label follow-up
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY, 2014, 261 : S119 - S119
  • [33] Fremanezumab Long-Term Efficacy and Safety: Interim Results of a One-Year Study
    Goadsby, P.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    Ning, X.
    Aycardi, E.
    HEADACHE, 2018, 58 : 166 - 166
  • [34] Safety of voluntary kidney donation long term follow up
    Gokulnath
    Siddiqua, M. Aesha
    Chetan, C. S.
    NEPHROLOGY, 2008, 13 : A84 - A84
  • [35] Long-term safety and efficacy of mavacamten in obstructive hypertrophic cardiomyopathy: up to 3.5-year follow-up results of the EXPLORER cohort of MAVA-Long-Term Extension study
    Garcia-Pavia, P.
    Oreziak, A.
    Masri, A.
    Barriales-Villa, R.
    Abraham, T. P.
    Owens, A. T.
    Jensen, M.
    Wojakowski, W.
    Seidler, T.
    Hagege, A.
    Balaratnam, G.
    Shah, A.
    Fox, S.
    Hegde, S. M.
    Olivotto, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [36] A long-term follow-up evaluation of electronic health record prescribing safety
    Abramson, Erika L.
    Malhotra, Sameer
    Osorio, S. Nena
    Edwards, Alison
    Cheriff, Adam
    Cole, Curtis
    Kaushal, Rainu
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2013, 20 (E1) : E52 - E58
  • [37] Comparison of safety, efficacy, and long-term follow-up between "one-step" and "step-up" approaches for infected pancreatic necrosis
    Zheng, Zhi
    Lu, Jiong-Di
    Ding, Yi-Xuan
    Guo, Yu-Lin
    Mei, Wen-Tong
    Qu, Yuan-Xu
    Cao, Feng
    Li, Fei
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (11): : 1372 - 1389
  • [38] Long Term Safety Results From the Endeavor Program: Four-Year Follow-up
    Mauri, Laura
    Cutlip, Donald E.
    Leon, Martin B.
    Kandzari, David E.
    Wijins, Wiliam
    Fajadet, Jean
    Massaro, Joseph M.
    Guo, Wei
    Meredith, Ian T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 124I - 125I
  • [39] LONG-TERM FOLLOW-UP STUDY ON EFFICACY AND SAFETY OF TOPIRAMATE (TPM) IN CHILDHOOD EPILEPSIES
    Rasmini, P.
    Besana, D.
    EPILEPSIA, 2009, 50 : 202 - 202
  • [40] Long-Term Follow-up of Ponatinib Efficacy and Safety in the Phase 2 PACE Trial
    Cortes, Jorge E.
    Kim, Dong-Wook
    Pinilla-Ibarz, Javier
    Le Coutre, Philipp
    Paquette, Ronald
    Chuah, Charles
    Nicolini, Franck E.
    Apperley, Jane F.
    Khoury, H. Jean
    Talpaz, Moshe
    DiPersio, John F.
    DeAngelo, Daniel J.
    Abruzzese, Elisabetta
    Rea, Delphine
    Baccarani, Michele
    Mueller, Martin C.
    Gambacorti-Passerini, Carlo
    Lustgarten, Stephanie
    Rivera, Victor M.
    Clackson, Tim
    Turner, Christopher D.
    Haluska, Frank G.
    Guilhot, Francois
    Deininger, Michael W.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Shah, Neil P.
    Kantarjian, Hagop M.
    BLOOD, 2014, 124 (21)
12345